Companion Diagnostics Market, Size, Share, Opportunities and Forecast, 2020-2027

SKU: DMD34 | Last Updated On: Apr 09 2020 | No. of Pages: 219 | Available Formats

> Global Companion Diagnostics Market Expected to reach a high CAGR of 18.30% By 2027: DataM Intelligence

Global Companion Diagnostics Market is segmented By Indications (Oncology (Colorectal Cancer, Leukemia, Breast Cancer, Lung Cancer, Others), Neurology, Others), By Technology (In-situ Hybridization, Immunohistochemistry, Polymerase Chain Reaction, Next-Generation Sequencing, Others), By End-User ( Pharmaceutical and Biopharmaceutical Companies, Research Laboratories, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share Outlook, and Opportunity Analysis, 2020-2027

Companion Diagnostics Market

Market Overview

  • Global Companion Diagnostics Market is expected to grow at a CAGR of 18.30% during the forecast period (2020-2027)   

Market Growth

  • The market is driven by several factors such as increased incidences of cancer, growing need for targeted therapies and favorable regulatory laws. The high cost of the drug development and lack of skilled professionals are the restraining factors that can affect the further growth of the market.

Market Segmentation

  • The global Companion Diagnostics market is segmented by Technology into Polymerase Chain Reaction, Next-Generation Sequencing, In-situ Hybridization, Immunohistochemistry, and Others. T
  • he polymerase chain reaction (PCR) segment accounted for the largest chunk of global companion diagnostics market share in 2016 due to the ease of use as it does not require too many samples for biomarker identification. The next-generation sequencing (NGS) segment is projected to grow during the forecast period.
  • Based on Indications, the market is segmented into Oncology (Colorectal Cancer, Leukemia, Breast Cancer, Lung Cancer, Others), Neurology, and Others.
  • The oncology segment occupies the largest part of the global companion diagnostics market share and is also the fastest growing segment due to increasing cases of cancer cases globally and rising number of clinical trials targeting cancer biomarkers for lung, breast, and prostate cancers.
  • Based on End User, the market is segmented into Pharmaceutical and Biopharmaceutical Companies, Research Laboratories, and Others. In 2016, the pharmaceutical and biopharmaceutical companies segment was the largest in terms of global companion devices market share and is estimated to grow during the forecast period due to increasing use of companion diagnostic kits among pharmaceutical and biopharmaceutical companies.
  • This increased use can be attributed to their benefits such as high efficiency (these kits enable the selection of the most suitable candidates for clinical trials) and cost reduction.
  • Geographically, the market is segmented into North America, South America, Europe, Asia Pacific and RoW. North America has the highest global market share due to the increasing technological advancements aimed at developing companion diagnostic tests for new indications such as neurology and infectious diseases.

Features of this report

  • The report covers the factors impacting the market, Porter 5 Forces, Market Share Analysis, Price trend analysis, Product Benchmarking, and company profiles.
  • The major companies in the Companion Diagnostics market includes F. Hoffmann-La Roche AG, Agilent Technologies Inc., Qiagen N.V., Thermo Fisher Scientific Inc., Abbott Laboratories, Inc., Biomérieux SA, Danaher Corporation, Illumina Inc., Myriad Genetics Inc., Arup Laboratories Inc., Sysmex Corporation, Hologic Inc., Novartis AG, Almac Group, and Abnova Corporation.

Key takeaways from this report

"The professional purchasing the DMI report on global sesame seeds market will be able to do the following":

  • Visualize the composition of the Companion Diagnostics in the market across each indication, in terms of type and applications, highlighting the key commercial assets and players.
  • Identify commercial opportunities in Companion Diagnostics by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of the Companion Diagnostics market – level 4/5 segmentation
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study
  • Product mapping in excel for the key Companion Diagnostics products of all major market players

Related Reports

Transfusion Diagnostics Market

Autoimmune Diagnostics Market


Table of Contents

1.Companion Diagnostics Market – Methodology and Scope

1.1 Research methodology

1.2 Scope of the Report

2 Companion Diagnostics Market -Trends

2.1 Key Trends & Developments

3 Companion Diagnostics Market – Industry Analysis

3.1 Industry Impact Factors (Drivers & Restraints)

3.2 Competitive Intensity- Porter 5 Forces

3.3 Regulatory Analysis

3.4 Production Analysis

4 Companion Diagnostics Market- Product Analysis

4.1. Companion Diagnostics Market – By Indications

4.1.1 Oncology Colorectal Cancer Leukemia Breast Cancer Lung Cancer Others

4.1.2 Neurology

4.1.3 Others

4.2. Companion Diagnostics Market – By Technology

4.2.1. In-situ Hybridization

4.2.2. Immunohistochemistry

4.2.3. Polymerase Chain Reaction

4.2.4 Next-Generation Sequencing

4.2.5 Others

4.3. Companion Diagnostics Market – By End User

4.3.1. Pharmaceutical and Biopharmaceutical Companies

4.3.2. Research Laboratories

4.3.3. Others

5 Companion Diagnostics Market- Geographical Analysis

5.1. Asia Pacific

5.1.1. China

5.1.2. Japan

5.1.3. India

5.1.4. Australia

5.1.5. Rest of Asia Pacific

5.2. Europe

5.2.1. Germany

5.2.2. France

5.2.3. The UK

5.2.4. Italy

5.2.5. Spain

5.2.6. Rest of Europe

5.3. North America

5.3.1. The USA

5.3.2. Canada

5.3.3. Mexico

5.4. South America

5.4.1. Brazil

5.4.2. Argentina

5.4.3. Rest of South America

5.5. RoW

6 Companion Diagnostics Market – Competitive Landscape

6.1 Market Share Analysis

6.2 Merger and Acquisition Analysis

6.3 New Product Launches

7  Companion Diagnostics Market- Company Profiles

7.1. F. Hoffmann-La Roche AG

7.2. Agilent Technologies, Inc.

7.3. Qiagen N.V.

7.4. Thermo Fisher Scientific Inc.

7.5. Abbott Laboratories, Inc.

7.6. Biomérieux SA

7.7. Danaher Corporation

7.8. Illumina, Inc.

7.9. Myriad Genetics, Inc.

7.10. Arup Laboratories Inc.

7.11. Sysmex Corporation

7.12. Hologic Inc.

7.13. Novartis AG

7.14. Almac Group

7.15. Abnova Corporation

8  Companion Diagnostics Market-Appendix

8.1 Sources

8.2 List of Tables

8.3 Expert Panel Validation

8.4 Disclaimer

8.5 Contact Us

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

Get your FREE SAMPLE PROPOSAL with a single click!